B Mirror Report : Al-Madina Pharmaceuticals Limited, a company listed on the SME platform of the capital market, has once again received a work order to export medicines from Afghanistan-based company Hejaz Limited.
The pharmaceutical and chemical sector company disclosed the information on Tuesday (January 20) through the Dhaka Stock Exchange (DSE).
According to the disclosure, Al-Madina Pharmaceuticals has received an export order worth USD 76,142.68 from Hejaz Limited of Afghanistan. Market insiders believe this order will further expand the company’s export activities in the international market and are optimistic that the new contract will have a positive impact on the company’s foreign currency earnings.
Previously, Al-Madina Pharmaceuticals had received an export order worth USD 123,218 from Hejaz Limited.
Al-Madina Pharmaceuticals Limited was listed on the capital market in 2023. The company has a paid-up capital of Tk 204 million, corresponding to a total of 24 million shares. As of June 30, 2025, sponsors and directors held 69.85 per cent of the shares, institutional investors 5.49 per cent, and general investors 24.66 per cent.
